An Annual Review of Important Apheresis Articles From the American Society for Apheresis Attending Physician Subcommittee
- PMID: 39564880
- DOI: 10.1002/jca.22152
An Annual Review of Important Apheresis Articles From the American Society for Apheresis Attending Physician Subcommittee
Abstract
In this first annual review article, the American Society for Apheresis (ASFA) Attending Physician Subcommittee (APSc) of the Physicians' Committee (PC) curated key apheresis literature in 2023 and presented their choices for the 10 most seminal apheresis articles. PubMed and OVID search engines were used to identify manuscripts from four topic areas: donor apheresis, therapeutic apheresis, education, and cellular therapy. To further identify seminal criteria, they had to present at least one of the following: novel findings, practice-altering outcomes, international scope, randomized controlled trial, relevant to current clinical practice, and/or provide evidence for category III or IV indications based on the ASFA ninth special issue of the Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach. Inclusion criteria included: full-length, peer-reviewed, English language, and human subjects. Case reports, review articles, and meta-analyses were excluded.
Keywords: apheresis education; cell therapy; donor apheresis; stem cell collection; therapeutic apheresis.
© 2024 Wiley Periodicals LLC.
References
-
- L. Connelly‐Smith, C. R. Alquist, N. A. Aqui, et al., “Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach From the Writing Committee of the American Society for Apheresis: The Ninth Special Issue,” Journal of Clinical Apheresis 38, no. 2 (2023): 77–278.
-
- K. B. Miller, T. F. Roberts, G. Chan, et al., “A Novel Reduced Intensity Regimen for Allogeneic Hematopoietic Stem Cell Transplantation Associated With a Reduced Incidence of Graft‐Versus‐Host Disease,” Bone Marrow Transplantation 33, no. 9 (2004): 881–889.
-
- P. J. Shaughnessy, B. J. Bolwell, K. van Besien, et al., “Extracorporeal Photopheresis for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation,” Bone Marrow Transplantation 45, no. 6 (2010): 1068–1076.
-
- C. L. Kitko, T. Braun, D. R. Couriel, et al., “Combination Therapy for Graft‐Versus‐Host Disease Prophylaxis With Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial,” Biology of Blood and Marrow Transplantation 22, no. 5 (2016): 862–868.
-
- S. H. Abhyankar, T. M. Yankee, D. S. Warhadpande, et al., “The Addition of Extracorporeal Photophoresis (ECP) to Tacrolimus and Methotrexate to Prevent Acute and Chronic Graft‐Versus Host Disease (aGvHD, cGvHD) in Patients Undergoing a Myeloablative (MA) Hematopoietic Cell Transplant (HCT),” Biology of Blood and Marrow Transplantation 20 (2014): S212–S213.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources